# WhiteCoat

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/whitecoat

- Industry: Healthcare IT
- Headquarters: Central Region, Singapore
- Website: www.whitecoat.com.sg
- Total disclosed funding: $6M
- Latest round: Series A (Jan 29, 2022)
- Investors on record: 5

## About

Founded in 2018 and based in Singapore, WhiteCoat Holdings Pte Ltd., dba WhiteCoat, operates as a provider of a platform that provides consultations to patients for common ailments and chronic illnesses. The company was founded by CEO Bryan Koh. In October 2024, WhiteCoat Global raised venture funding led by Raffles Family Office. Other investors MDI Ventures and SB Investment Advisers also participated in the round.

WhiteCoat Global provides a telehealth platform called the WhiteCoat app, that allows patients to consult doctors on a video chat on their mobile phones and treat general illnesses such as upper respiratory tract infection (URTI), fever, headache, gastroenteritis (GET), urinary tract infection (UTI), eye and skin conditions, musculoskeletal pain, etc; and chronic diseases such as hypertension, hyperlipidemia, and diabetes. The platform also provides the medical history and documents of the patients after the consultation.

## Funding rounds

- Series A, Jan 29, 2022, $6M — SGInnovate, Korea Investment Partners, Golden Equator Capital, Dexa International, Thomson X

## Investors

- SGInnovate (https://capitalatlas.ai/funds/sginnovate) — Series A
- Korea Investment Partners (https://capitalatlas.ai/funds/korea-investment-partners) — Series A
- Golden Equator Capital (https://capitalatlas.ai/funds/golden-equator-capital) — Series A
- Dexa International (https://capitalatlas.ai/funds/dexa-international) — Series A
- Thomson X — Series A